WHO世界卫生组织：2025年世界卫生组织药物信息报告-第39卷，第1期（英文版）

This guideline aims to highlight areas of specific attention when developing medicines for children, however, general regulatory principles of quality for the development of medicines should be followed. Safe and effective pharmacotherapy for the paediatric population requires the availability of age-appropriate medications and information for correct prescribing and administration in relation to age, physiological condition and body size of the child. Formulations developed specifically for